Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Burston

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Proceedings of the Nutrition Society|October 24, 2013
Endocannabinoid system and pain: an introductionJames J Burston, Stephen G Woodhams
Pharmacology, Biochemistry, and Behavior|November 28, 2009
Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in ratsJenny L Wiley, James J Burston
Neuroscience Letters|June 10, 2014
Sex differences in Δ(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent ratsJenny L Wiley, James J Burston
Handbook of Experimental Pharmacology|April 8, 2015
The role of the endocannabinoid system in painStephen G Woodhams, Devi Rani Sagar, James J Burston, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 31, 2012
Dynamic changes to the endocannabinoid system in models of chronic painDevi Rani Sagar, James J Burston, Stephen G Woodhams, et al.
British Journal of Pharmacology|August 20, 2010
Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposureJames J Burston, Jenny L Wiley, Abimbola A Craig, et al.
Plos One|September 29, 2020
Refining surgical models of osteoarthritis in mice and rats alters pain phenotype but not joint pathologyPeter R W Gowler, Paul I Mapp, James J Burston, et al.
Neuropharmacology|August 19, 2008
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in ratsJenny L Wiley, Seth H Kendler, James J Burston, et al.
British Journal of Pharmacology|March 22, 2005
CB1 cannabinoid receptor-mediated modulation of food intake in miceJenny L Wiley, James J Burston, Darnica C Leggett, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2008
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipaseJames J Burston, Laura J Sim-Selley, John P Harloe, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Proceedings of the Nutrition Society|October 24, 2013
Endocannabinoid system and pain: an introductionJames J Burston, Stephen G Woodhams
Pharmacology, Biochemistry, and Behavior|November 28, 2009
Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in ratsJenny L Wiley, James J Burston
Neuroscience Letters|June 10, 2014
Sex differences in Δ(9)-tetrahydrocannabinol metabolism and in vivo pharmacology following acute and repeated dosing in adolescent ratsJenny L Wiley, James J Burston
Handbook of Experimental Pharmacology|April 8, 2015
The role of the endocannabinoid system in painStephen G Woodhams, Devi Rani Sagar, James J Burston, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 31, 2012
Dynamic changes to the endocannabinoid system in models of chronic painDevi Rani Sagar, James J Burston, Stephen G Woodhams, et al.
British Journal of Pharmacology|August 20, 2010
Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposureJames J Burston, Jenny L Wiley, Abimbola A Craig, et al.
Plos One|September 29, 2020
Refining surgical models of osteoarthritis in mice and rats alters pain phenotype but not joint pathologyPeter R W Gowler, Paul I Mapp, James J Burston, et al.
Neuropharmacology|August 19, 2008
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in ratsJenny L Wiley, Seth H Kendler, James J Burston, et al.
British Journal of Pharmacology|March 22, 2005
CB1 cannabinoid receptor-mediated modulation of food intake in miceJenny L Wiley, James J Burston, Darnica C Leggett, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2008
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipaseJames J Burston, Laura J Sim-Selley, John P Harloe, et al.
Pageof 4